NARI News and Press, Inari Medical Inc. From 05/27/24

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Inari Medical To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - May 27, 2024) - Faruqi & Faruqi, LLP, a leading natio...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Inari Medical To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - May 23, 2024) - Faruqi & Faruqi, LLP, a leading natio...

IRVINE, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that it had filed a patent infringement lawsu...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Inari Medical To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - May 19, 2024) - Faruqi & Faruqi, LLP, a leading natio...

NEW YORK, NY / ACCESSWIRE / May 16, 2024 / Bernstein Liebhard LLP: Do you, or did you, own shares of Inari Medical, Inc. (NASDAQ:NARI)? Did you purchase your shares between February 24, 2022 and February 28, 2024, inclusive? Did you lose money in your investment in Inari Medical, I...

SAN FRANCISCO, May 14, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses now . Class Period: Feb. 24, 2022 – Feb. 28, 2024 Lead Plaintiff Deadline: July 12, 2024 Visit:...

2024-05-09 13:22:28 ET More on Novo Nordisk The FTC Cracks Down On Novo Nordisk's Ozempic Novo Nordisk A/S 2024 Q1 - Results - Earnings Call Presentation Novo Nordisk A/S (NVO) Q1 2024 Earnings Call Transcript Catalent, Novo Nordisk receive FTC request for mo...

IRVINE, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today its management team will present at the upcom...

2024-05-03 07:15:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. During the first quarter of 2024, Baron Discovery Fund® (the Fund) was up 4.57% (...

2024-05-01 03:32:02 ET Inari Medical, Inc. (NARI) Q1 2024 Earnings Conference Call April 30, 2024, 16:30 PM ET Company Participants John Hsu - Vice President, Investor Relations Drew Hykes - Chief Executive Officer Mitch Hill - Chief Financial Officer Tom Tu ...